Treatment of Genotype 4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin

By Al-hamoudi Waleed   Mohamed Hazem   Abaalkhail Faisal   Kamel Yaser   Al-Masri Nasser   Allam Naglaa   Alqahtani Saleh   Al-Sofayan Mohammed   Khalaf Hatem   Al-Sebayel Mohammed   Al-jedai Ahmed   Abdo Ayman  

Digestive Diseases and Sciences, Vol. 56, Iss. 6, 2011-06 ,pp. : 1848-1852

Springer Publishing Company

Access to resources Recommend Favorite

Three-year follow-up of pegylated interferon alfa-2b as monotherapy or in combination with lamivudine in patients with HBeAg-negative chronic hepatitis B

By Papadopoulos Vasileios   Protopapas Andreas   Tsianos Epameinondas   Mimidis Konstantinos  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 8, 2009-08 ,pp. : 1021-1022

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of Interferon Alfa-2b With and Without Ribavirin as Therapy for Chronic Hepatitis C in Sweden

By Sennfält K.   Reichard O.   Hultkrantz R.   Wong J. B.   Jonsson D.  

Scandinavian Journal of Gastroenterology, Vol. 36, Iss. 8, 2001-08 ,pp. : 870-876

Informa Healthcare

Access to resources Recommend Favorite

Pegylated Interferon α -2a With or Without Ribavirin in HCV/HIV Coinfection: Partially Blinded, Randomized Multicenter Trial

By Khalili Mandana   Bernstein David   Lentz Ellen   Barylski Christine   Hoffman-Terry Margaret  

Digestive Diseases and Sciences, Vol. 50, Iss. 6, 2005-06 ,pp. : 1148-1155

Springer Publishing Company

Access to resources Recommend Favorite

Successful Treatment With Novel Triple Drug Combination Consisting of Interferon-γ, Interferon Alfacon-1, and Ribavirin in a Nonresponder HCV Patient to Pegylated Interferon Therapy

By Balan Vijayan   Rosati Marianne   Anderson Machiko   Rakela Jorge  

Digestive Diseases and Sciences, Vol. 51, Iss. 5, 2006-05 ,pp. : 956-959

Springer Publishing Company

Access to resources Recommend Favorite